,

Chronic Myeloid Leukemia

Paperback Engels 2019 9780367453305
€ 95,89
Levertijd ± 8 werkdagen
Gratis verzonden

Samenvatting

Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and trends in the treatment of CML and provides an authoritative and convenient summary of the latest progress in imatinib trials, the molecular monitoring of CML responses, and the engineering of new therapies to overcome resistance and improve patient care.

Providing critical insight and exploration of models that will enhance the cancer community at large, this source:

stands as the only source to focus on post-Gleevec developments in CML therapeutics

collects information from the forefront of the field—helping busy clinicians make informed management decisions

supplies critical research from recognized opinion leaders on the topic

provides an overview of the current status of new transplant modalities

contains a vivid selection of color photographs

Specificaties

ISBN13:9780367453305
Taal:Engels
Bindwijze:Paperback
Aantal pagina's:172
Uitgever:Taylor & Francis Ltd

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

BCR-ABL as a Molecular Target. Long-Term Results of Stem Cell Transplant. Where are We Today with Imatinib Therapy. Monitoring CML in 2006. Monitoring CML in 2006. Dasatinib: a Dual Abl and Src Inhibitor. AMN107. Resistance to Imatinib. Immunotherapy. Non-Immunological, non TKI Targets. Non-Immunological, non TKI Targets. CML in Transformation. Early Intensification of Therapy

Managementboek Top 100

€ 95,89
Levertijd ongeveer 8 werkdagen
Gratis verzonden

Rubrieken

Producten

    Auteurs

      Trefwoorden

        Artikelen

          Chronic Myeloid Leukemia